Management of treatment resistance in the depressed geriatric patient (Q41127942)

27 September 2017

1 reference

title

Management of treatment resistance in the depressed geriatric patient (English)

1 reference

27 September 2017

Kamholz BA

1 reference

27 September 2017

Mellow AM

series ordinal

1 reference

27 September 2017

publication date

1 June 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

269-286

1 reference

The course of geriatric depression with "reversible dementia": a controlled study

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Late-onset depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Fluoxetine efficacy in treatment resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Contemporary management of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Fluoxetine potentiation by buspirone: three case histories

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Depression in old age. A reconsideration of cerebral disease in relation to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The pharmacokinetics of paroxetine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Major depression with melancholia: a comparison of middle-aged and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Prognosis of depression in the elderly. A comparison with younger patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Psychiatric disorders and 15-month mortality in a community sample of older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Fluoxetine in elderly patients: is there cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The treatment of refractory depression using paroxetine with lithium augmentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The neuropsychology of depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Sodium valproate augmentation of fluoxetine or fluvoxamine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Efficacy of fluvoxamine in treatment-refractory depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Absence of cognitive impairment after more than 100 lifetime ECT treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Pharmacokinetics of the newer antidepressants: clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Fluoxetine and desipramine: a strategy for augmenting anti-depressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Bupropion in Tricyclic Antidepressant Nonresponders with Unipolar Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Masked depression. Help for the hidden misery

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Recent developments in geriatric psychopharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Somatic complaints and the CES-D

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The pharmacokinetics of tricyclic antidepressant drugs in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Social support and the outcome of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Affective disorders in the elderly: diagnostic and research considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Physical Comorbidity in Elderly Veterans Affairs Patients With Schizophrenia and Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Delusional depression. A distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment-resistant depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Analysis of time to stabilization in the treatment of depression: biological and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Unrecognized physical illness prompting psychiatric admission: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Recovery and relapse from major depressive disorder in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Factors associated with recovery from and relapse into major depressive disorder in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Pharmacotherapy of Dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Association of antidepressants and other medications with mortality in the residential-care elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Recent pharmacologic advances in antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Survival and health care utilization in elderly medical inpatients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Leukoencephalopathy in patients diagnosed as major depressive

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Electroconvulsive Therapy for Major Depression in the Oldest Old: Effects of Medical Comorbidity on Post-Treatment Survival

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Lithium augmentation for treatment-resistant depression in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Efficacy of phenelzine in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Using Tricyclic Antidepressants in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment resistant depression: a clinical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Prognosis of Depression in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Lithium side effects in the medically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The prognosis of depression in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Increased mortality rates in late-life depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Pharmacokinetic aspects of antidepressant treatment in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

A preliminary magnetic resonance imaging study of ECT-treated depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Depression and Mortality Among Institutionalized Aged

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The management and nature of depressive illnesses in late life: a follow-through study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Medication resistance and clinical response to electroconvulsive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Cortical magnetic resonance imaging changes in elderly inpatients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment of depression in late life

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment of consecutive episodes of major depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Open-trial response to antidepressant treatment in elderly patients with mixed depression and cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Suspected dementia: psychiatric differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Fluoxetine-nortriptyline therapy of treatment-resistant major depression in a geriatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Depression and mortality in nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Response to Treatment of Depression in the Old and Very Old

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Coexisting dementia and depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

United States experience with trazodone: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Memory functions as affected by electroconvulsive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Advances in pharmacotherapy: depression in the elderly--issues and advances in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Long-term outcome of treatment-resistant depression in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

High-dose selegiline in treatment-resistant older depressive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Refractory Depression: Relevance of Psychosocial Factors and Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Lithium augmentation in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Delirium associated with bupropion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Cognitive dysfunction associated with antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Treatment resistant depression in an Australian context. II: Outcome of a series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Overview of depression and psychosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

Detecting depression in elderly medical inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970288-4

7 January 2021

10.1016/S0193-953X(05)70288-4

Identifiers

DOI

1 reference

release_zwmttqzmr5gfzml4tzi6pq6324

27 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zwmttqzmr5gfzml4tzi6pq6324

24 November 2022

mapped directly with Wikidata item

1 reference